Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001696891 | SCV000569566 | likely benign | not provided | 2020-12-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000479684 | SCV000593569 | likely benign | not specified | 2016-06-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000530462 | SCV000654123 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003942589 | SCV004759002 | benign | B4GAT1-related disorder | 2023-01-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |